These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
643 related articles for article (PubMed ID: 16100037)
1. Reduced vascular remodeling, endothelial dysfunction, and oxidative stress in resistance arteries of angiotensin II-infused macrophage colony-stimulating factor-deficient mice: evidence for a role in inflammation in angiotensin-induced vascular injury. De Ciuceis C; Amiri F; Brassard P; Endemann DH; Touyz RM; Schiffrin EL Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2106-13. PubMed ID: 16100037 [TBL] [Abstract][Full Text] [Related]
2. Effect of hyperhomocystinemia and hypertension on endothelial function in methylenetetrahydrofolate reductase-deficient mice. Virdis A; Iglarz M; Neves MF; Amiri F; Touyz RM; Rozen R; Schiffrin EL Arterioscler Thromb Vasc Biol; 2003 Aug; 23(8):1352-7. PubMed ID: 12829522 [TBL] [Abstract][Full Text] [Related]
3. Resistance artery remodeling in deoxycorticosterone acetate-salt hypertension is dependent on vascular inflammation: evidence from m-CSF-deficient mice. Ko EA; Amiri F; Pandey NR; Javeshghani D; Leibovitz E; Touyz RM; Schiffrin EL Am J Physiol Heart Circ Physiol; 2007 Apr; 292(4):H1789-95. PubMed ID: 17142347 [TBL] [Abstract][Full Text] [Related]
4. Deleterious combined effects of salt-loading and endothelial cell restricted endothelin-1 overexpression on blood pressure and vascular function in mice. Amiri F; Ko EA; Javeshghani D; Reudelhuber TL; Schiffrin EL J Hypertens; 2010 Jun; 28(6):1243-51. PubMed ID: 20308920 [TBL] [Abstract][Full Text] [Related]
5. Angiotensin II induces vascular dysfunction without exacerbating blood pressure elevation in a mouse model of menopause-associated hypertension. Javeshghani D; Sairam MR; Neves MF; Schiffrin EL; Touyz RM J Hypertens; 2006 Jul; 24(7):1365-73. PubMed ID: 16794486 [TBL] [Abstract][Full Text] [Related]
6. Evidence that nitric oxide inhibits vascular inflammation and superoxide production via a p47phox-dependent mechanism in mice. Harrison CB; Drummond GR; Sobey CG; Selemidis S Clin Exp Pharmacol Physiol; 2010 Apr; 37(4):429-34. PubMed ID: 19843095 [TBL] [Abstract][Full Text] [Related]
7. Ets-1 is a critical transcriptional regulator of reactive oxygen species and p47(phox) gene expression in response to angiotensin II. Ni W; Zhan Y; He H; Maynard E; Balschi JA; Oettgen P Circ Res; 2007 Nov; 101(10):985-94. PubMed ID: 17872466 [TBL] [Abstract][Full Text] [Related]
9. IL-6 deficiency protects against angiotensin II induced endothelial dysfunction and hypertrophy. Schrader LI; Kinzenbaw DA; Johnson AW; Faraci FM; Didion SP Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2576-81. PubMed ID: 17962626 [TBL] [Abstract][Full Text] [Related]
10. Vascular smooth muscle cell NAD(P)H oxidase activity during the development of hypertension: Effect of angiotensin II and role of insulinlike growth factor-1 receptor transactivation. Cruzado MC; Risler NR; Miatello RM; Yao G; Schiffrin EL; Touyz RM Am J Hypertens; 2005 Jan; 18(1):81-7. PubMed ID: 15691621 [TBL] [Abstract][Full Text] [Related]
11. Essential role of angiotensin II type 1a receptors in the host vascular wall, but not the bone marrow, in the pathogenesis of angiotensin II-induced atherosclerosis. Koga J; Egashira K; Matoba T; Kubo M; Ihara Y; Iwai M; Horiuchi M; Sunagawa K Hypertens Res; 2008 Sep; 31(9):1791-800. PubMed ID: 18971558 [TBL] [Abstract][Full Text] [Related]
12. Opposing roles of p47phox in basal versus angiotensin II-stimulated alterations in vascular O2- production, vascular tone, and mitogen-activated protein kinase activation. Li JM; Wheatcroft S; Fan LM; Kearney MT; Shah AM Circulation; 2004 Mar; 109(10):1307-13. PubMed ID: 14993144 [TBL] [Abstract][Full Text] [Related]
13. Lysozyme M-positive monocytes mediate angiotensin II-induced arterial hypertension and vascular dysfunction. Wenzel P; Knorr M; Kossmann S; Stratmann J; Hausding M; Schuhmacher S; Karbach SH; Schwenk M; Yogev N; Schulz E; Oelze M; Grabbe S; Jonuleit H; Becker C; Daiber A; Waisman A; Münzel T Circulation; 2011 Sep; 124(12):1370-81. PubMed ID: 21875910 [TBL] [Abstract][Full Text] [Related]
14. Endothelium-restricted overexpression of human endothelin-1 causes vascular remodeling and endothelial dysfunction. Amiri F; Virdis A; Neves MF; Iglarz M; Seidah NG; Touyz RM; Reudelhuber TL; Schiffrin EL Circulation; 2004 Oct; 110(15):2233-40. PubMed ID: 15466627 [TBL] [Abstract][Full Text] [Related]
15. Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice. Virdis A; Neves MF; Amiri F; Touyz RM; Schiffrin EL J Hypertens; 2004 Mar; 22(3):535-42. PubMed ID: 15076159 [TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-1 is involved in endothelial dysfunction of mesenteric small arteries from angiotensin II-infused mice. Virdis A; Colucci R; Fornai M; Duranti E; Giannarelli C; Bernardini N; Segnani C; Ippolito C; Antonioli L; Blandizzi C; Taddei S; Salvetti A; Del Tacca M Hypertension; 2007 Mar; 49(3):679-86. PubMed ID: 17145980 [TBL] [Abstract][Full Text] [Related]
17. Impact of regular physical activity on the NAD(P)H oxidase and angiotensin receptor system in patients with coronary artery disease. Adams V; Linke A; Kränkel N; Erbs S; Gielen S; Möbius-Winkler S; Gummert JF; Mohr FW; Schuler G; Hambrecht R Circulation; 2005 Feb; 111(5):555-62. PubMed ID: 15699275 [TBL] [Abstract][Full Text] [Related]
18. Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice. Matsuno K; Yamada H; Iwata K; Jin D; Katsuyama M; Matsuki M; Takai S; Yamanishi K; Miyazaki M; Matsubara H; Yabe-Nishimura C Circulation; 2005 Oct; 112(17):2677-85. PubMed ID: 16246966 [TBL] [Abstract][Full Text] [Related]